| Summary of
the updates from January to June 2003 |
June 2003 |
|
The most significant changes of 3.5 version are listed below:
NEW
|
 Country
page - new presentations of the MALARIA section |
The malaria section
has been adapted according to the new CDC recommendations for alternative
drugs for prophylaxis.The elements of this section appear in new order
and a new document is accessible from this section to facilitate drug
choice. Included are:
- Details on the risk areas
- Transmission months, Predominant species, Chloroquine resistant
and Mosquito protection
- Recommended Chemoprophylaxis and Presumptive Self-Treatment
for travelers who elect NOT to take or are unable to take appropriate
chemoprophylaxis
- New document " Drug Choice Considerations", giving
the Pros and Cons About Drugs for Chemoprophylaxis and Presumptive
Self-treatment.
|
Recommended drugs for the Chemoprophylaxis
of Malaria
The drugs for chemoprophylaxis are now listed as alternatives. Drugs
are listed alphabetically (as CDC lists them) and not in order of preference.The
document " Drug Choice Considerations" gives the information
for choosing the appropriate drug. For example:
- Areas with chloroquine-sensitive
malaria: chloroquine (Aralen)
- Areas with chloroquine-resistant malaria: atovaquone-proguanil
(Malarone), doxycycline or mefloquine (Lariam)
- Areas with mefloquine-resistant malaria: atovaquone-proguanil
(Malarone) or doxycycline
|
Recommended drug for the Presumptive
Self-treatment
Complete revision of risks, immunization recommendations and comments
in all countries for:
- For travelers who elect NOT to take or are unable to take appropriate
chemoprophylaxis: atovaquone-proguanil (Malarone)
|
  New
Documents
Recommendations - Malaria
- Presumptive Self-Treatment for Suspected Malaria (accessible
also from the malaria table of the country pages)
- Malaria - Pros and Cons About Drugs for Chemoprophylaxis and
Presumptive Self-treatment (accessible from the malaria table
of the country pages as "Drug Choice
Considerations")
Traveler-related risks - Children
- Child Adoption Abroad - Vaccination and Other Recommendations
for Parents Wishing to Adopt [Handout]
|
UPDATES AND REVISIONS
|
|
Country
information
Updates according to the CDC Health Information for International
Travel, 2003-2004 (Yellow Book) |
- Malaria: Areas of risk, Chloroquine resistance and Recommended
prophylaxis (yellow pages 15-40)
- Yellow Fever: Requirements and CDC recommendations (yellow pages15-40)
|
 Maps
Malaria |
- Countries - Malaria Endemic Areas: all maps according to the CDC
book (yellow pages 15-40)
- Africa, Americas and Asia - Malaria Endemic countries: continent
maps indicating Chloroquine-Resistant and Chloroquine-Sensitive Areas
according to the CDC book (pages 104-105)
Meningococcal Meningitis
|
- Africa - Meningococcal Meningitis
Epidemic Areas: Areas with Frequent Epidemics according to the CDC
book (page 121)
Yellow Fever |
- Africa and Americas - Yellow Fever
Endemic Areas: continent maps according to the CDC book (pages 160-161)
Tick-Borne Encephalitis |
- Germany and Switzerland - Tick-Borne
Encephalitis Endemic Areas, according to official sources of these
countries, 2003
|
Recommendations
Malaria (new revisions) |
- Malaria Prevention
- Malaria Tratment
- Atovaquone-Proguanil - Prevention of Malaria
- Atovaquone-Proguanil - Presumptive Treatment of Malaria
- Chloroquine - Prevention of Malaria
- Doxycycline - Prevention of Malaria
- Mefloquine - Prevention of Malaria
- Sulfadoxine-pyrimethamine - Presumptive Treatment of Malaria
Vaccinations (new revisions) |
- Recommended Childhood Immunization
Schedule, 2003
- Vaccination against Hepatitis A
- Vaccination against Hepatitis B
- Vaccination against Poliomyelitis
- Vaccination against Typhoid Fever
- Vaccination against Yellow Fever
Other (new revisions) |
|
|
|  Diseases
New revisions |
|
|
 Addresses
Update |
- Addresses for
U.S. embassies and consulates
|
Next CD-ROM in November 2003
|
